Similar articles

• Novel pH1N1 viral cardiomyopathy requiring veno-venous extracorporeal membrane oxygenation.

  Subramanian S, Clark JD, Jeffries HE, McMullan DM. Subramanian S, et al. Pediatr Crit Care Med. 2010 Nov;11(6):714-7. doi: 10.1097/PCC.0b013e3181e327c9. Pediatr Crit Care Med. 2010. PMID: 20453697
• Extracorporeal membrane oxygenation in pandemic flu: insufficient evidence or worth the effort?

  Dalton HJ, MacLaren G. Dalton HJ, et al. Crit Care Med. 2010 Jun;38(6):1484-5. doi: 10.1097/CCM.0b013e3181e08fff. Crit Care Med. 2010. PMID: 20502139 No abstract available.
• Clinical features of a Dutch cohort of critically ill children due to the 2009 new influenza A H1N1 pandemic.

  van Zwol A, Witteveen R, Markhorst D, Geukers VG. van Zwol A, et al. Clin Pediatr (Phila). 2011 Jan;50(1):69-72. doi: 10.1177/0009922810381426. Epub 2010 Sep 13. Clin Pediatr (Phila). 2011. PMID: 20837610
• Extracorporeal membrane oxygenation in the context of the 2009 H1N1 influenza A pandemic.

  Sihler KC, Park PK. Sihler KC, et al. Surg Infect (Larchmt). 2011 Apr;12(2):151-8. doi: 10.1089/sur.2010.082. Surg Infect (Larchmt). 2011. PMID: 21545282 Review.
• Infection control in mass respiratory failure: preparing to respond to H1N1.

  Daugherty EL, Branson RD, Deveraux A, Rubinson L. Daugherty EL, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e103-9. doi: 10.1097/CCM.0b013e3181c6697a. Crit Care Med. 2010. PMID: 19901827 Review.